97074 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
Aptamer-modified polymeric materials for the binding of factors in a wound environment
#902Respiratory syncytial virus vaccine
#903Agents that specifically bind matrilin-3 and their use
#904Fibroin-derived protein composition
#905Col 11A1 AND NOVEL FRAGMENT THEREOF FOR REGULATION OF BONE MINERALIZATION
#906Reconstituted nipple skin model
#907Prostate specific membrane antigen binding fibronectin type III domains
#908Method for continuous production of degradation product of water-insoluble polymeric compound
#909METHODS FOR DEPYROGENATION OF PROTEINS
#910Collagen-based injectable preparations capable of controlling bleeding and/or of substituting for platelets in the case of haemorrhagic syndromes
#911SPARC binding ScFvs
#912METHOD FOR PRODUCING BIOCOMPATIBLE MACROMOLECULAR POROUS BODY, BIOCOMPATIBLE MACROMOLECULAR POROUS BODY, BIOCOMPATIBLE MACROMOLECULAR BLOCK AND CELL STRUCTURE
#913Inhibitors of type 2 vascular endothelial growth factor receptors
#914Composition and method for therapeutic agent delivery during pregnancy
#915CELL-FREE IN VITRO MODELS FOR TRAUMATIC BRAIN INJURY AND METHODS FOR PREPARATION AND USE THEREOF
#916Methods for stimulation of appetite and increase in weight by administration of asprosin
#917Biochemical markers for CVD risk assessment
#918Peptide-based nanofibrillar materials
#919Glycation Cross-link Breakers to Increase Resistance to Enzymatic Degradation
#920Cross-linked resilin-containing materials
#921Polypeptide composition and culture method for pluripotent stem cell using same
#922Hydrogels formed from polypeptide micelles and methods of use thereof
#923Stabilized fibronectin domain compositions, methods and uses
#924Use of endostatin peptides for the treatment of fibrosis
#925Collagen-binding synthetic peptidoglycans, preparation, and methods of use
#926Connective tissue stimulating peptides
#927Method for preparing a fibrillar collagen matrix
#928Composition comprising neural cell and elastin-like polypeptide for treating Parkinson's disease
#929Prevention of tissue ischemia and related methods
#930Compositions comprising the NC2 domain of collagen IX and methods of using same
#931Self-assembling underwater adhesives
#932AGENTS AND METHODS BASED ON THE USE OF THE EDA DOMAIN OF FIBRONECTIN
#933Pharmaceutical composition for preventing or treating ocular surface disease
#934Use of gelatin or deeply processed gelatin materials in preparation of hair quality-improving compositions
#935SPARC (secreted protein, acidic and rich in cysteine), a new target for the treatment and prevention of acute liver failure
#936Composition for treating hyperlipidemia comprising oxyntomodulin derivative
#937Regeneration of Damaged Tissue
#938PEPTIDES AND USES THEREOF
#939Method of improving the pharmacokinetic profile of a therapeutic polypeptide and the use thereof
#940Silk-elastin like protein polymers for embolization and chemoembolization to treat cancer
#941Thrombospondin-1 polypeptides and methods of using same
#942GENERATION OF HEMOGLOBIN-BASED OXYGEN CARRIERS USING ELASTIN-LIKE POLYPEPTIDES
#943Trimeric antigen binding molecules
#944System and Method for Collagen Isolation
#945Fibronectin based scaffold domain proteins that bind PCSK9
#946Targeted therapeutics based on engineered proteins that bind EGFR
#947FIBRONECTIN BASED SCAFFOLD DOMAINS LINKED TO SERUM ALBUMIN OR MOIETY BINDING THERETO
#948Reagents and methods for treating dental disease
#949Amniotic membrane preparations and purified compositions and anti-inflammation methods
#950Materials and methods for the treatment of pathological neovascularization in the eye
#951Cell culture vessel coated with laminin fragment in dry state
#952Complexes of types of MHC class II that bind to collagen type II peptides and their use on diagnosis and treatment
#953Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
#954Purified amniotic membrane compositions and methods of use
#955CROSSLINKED HUMAN OR ANIMAL TISSUE PRODUCTS AND THEIR METHODS OF MANUFACTURE AND USE
#956ENGINEERED LEATHER AND METHODS OF MANUFACTURE THEREOF
#957Fibroin-derived protein composition
#958Antibacterial cornea repair material and preparation method thereof
#959COLLAGEN POWDER
#960MODIFIED COLLAGEN MOLECULES
#961Optimal interstrand bridge for collagen mimics
#962Trap 63
#963Scalable three-dimensional elastic construct manufacturing
#964COMPOSITIONS AND METHODS FOR INHIBITING CHEMORESISTANCE IN CANCER AND IMPROVING RESPONSE TO THERAPY
#965INDUCTION OF ANTIGEN-SPECIFIC TOLERANCE
#966Modified laminin containing collagen binding molecule and use thereof
#967METHOD FOR ISOLATING COLLAGEN FROM JELLYFISH BY USING RADIATION
#968Purification of triple helical proteins
#969Controlled cross-linking processing of proteins
#970Fibronectin type III domain based scaffold compositions, methods and uses
#971Method and Pharmaceutical Composition for use in the Treatment of Cancer
#972Therapeutic agents comprising a GLP-2 peptide and elastin-like peptides
#973Reconstituted polypeptides
#974Synthetic peptides for the treatment of autoimmune diseases
#975Protein nanofibers from self-assembling pentamers
#976Fibulin protein variants and corresponding nucleic acid sequences
#977Collagen materials and methods for obtaining same
#978Tissue repair material
#979High pH protein refolding methods
#980Regulatory T cell epitopes, compositions and uses thereof
#981Electrochemical processing of materials, methods and production
#982Methods, compositions and systems for production of recombinant spider silk polypeptides
#983Tangential flow filtration based protein refolding methods
#984COMPOUNDS THAT BIND DYSTROGLYCAN AND USES THEREOF
#985Methods compositions and systems for production of recombinant spider silk polypeptides
#986Vitronectin-derived cell culture substrate for maintaining human pluripotent stem cells in a substantially undifferentiated state
#987Fibronectin type III domain proteins with enhanced solubility
#988Collagen scaffolds
#989FIBRONECTIN BASED SCAFFOLD PROTEINS
#990Mechanochemical collagen assembly
#991Method for use of a double-structured tissue implant for treatment of tissue defects
#992Fusion proteins that facilitate cancer cell destruction
#993TREATMENT OF SKIN DISORDERS
#994Mutants of streptokinase and their covalently modified forms
#995PARTIAL PURIFICATION METHOD FOR HYDROPHILIC RECOMBINANT PROTEIN
#996Use of compounds that selectively modulate astrocytic release of substances through hemichannels of connexins and pannexins, without influencing gap junctions, for the treatment of psychiatric disorders
#997Generating targeted sequence diversity in proteins
#998EXTRACTION METHOD FOR HYDROPHILIC RECOMBINANT PROTEIN
#999Method and apparatus for data transmission using multiple transmit antennas
#1000Method for treating heart disease by inhibiting the Coxsackievirus-Adenovirus Receptor
#1001MIMETIC PEPTIDES DERIVED FROM COLLAGEN TYPE IV AND THEIR USE FOR TREATING ANGIOGENESIS- AND LYMPHANGIOGENESIS- DEPENDENT DISEASES
#1002Determining pathological cartilage turnover
#1003Collagen fibrillar construction
#1004Adenovirus vectors
#1005Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices
#1006Method for producing a collagen membrane and uses thereof
#1007Chimeric fibronectin matrix mimetics and uses thereof
#1008Collagen-derived recombinant proteins with von Willebrand factor-binding activity
#1009Fibronectin based scaffold domain proteins that bind IL-23
#1010Elastic hydrogel
#1011Artificial blood vessel, and method for producing artificial blood vessel
#1012Method of treating cancer by administering EGFR and EGFR/IGFIR binding molecules
#1013TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS FOR TYROSINE KINASES RECEPTORS, INCLUDING IGF-IR
#1014Self-assembling collagen-like polypeptide sequences for applications and uses related thereto
#1015Generating targeted sequence diversity in fusion proteins
#1016Process for the preparation of gelatin
#1017ICAM-1 TARGETING ELPS
#1018Production and delivery of a stable collagen
#1019Collagen hydrolysate and use thereof
#1020NOVEL PEPTIDES THAT BIND TO TYPES OF MHC CLASS II AND THEIR USE ON DIAGNOSIS AND TREATMENT
#1021CD20 scFv-ELPs METHODS AND THERAPEUTICS
#1022SELF-ASSEMBLING PEPTIDES, PEPTIDE NANOSTRUCTURES AND USES THEREOF
#1023Modified fibronectin fragments or variants and uses thereof
#1024METHODS AND SMALL MOLECULE THERAPEUTICS COMPRISING FUSED ELPS
#1025Method of Making Collagen Powder From Marine Cartilage and Skin
#1026METHOD OF MAKING COLLAGEN POWDER FROM MARINE CARTILAGE AND SKIN
#1027Compositions and methods for brown fat induction and activity using FNDC5
#1028Matrix scaffold with antimicrobial activity
#1029Pulse combustion drying of proteins
#1030COMPOSITION FOR TREATING HYPERLIPIDEMIA COMPRISING OXYNTOMODULIN DERIVATIVE
#1031Collagen peptide composition production method, DPP-4 inhibitor, and antihyperglycemic agent
#1032Polypeptide, scaffold composition, composition for cartilage tissue restoration, composition for cartilage cell culture, and composition for promoting glycosaminoglycan production
#1033Bone regeneration agent including gelatin
#1034Matrix metalloproteinase cleavable protein polymers for cancer gene therapy
#1035Serum albumin binding molecules
#1036Method for Fractionally Extracting Mucin and Collagen
#1037Targeted therapy for the prevention of restenosis in the cardiovascular system
#1038Cross-linked collagen comprising metallic anticancer agents
#1039Nanoscale collagen particles and membranes
#1040Methods and Uses for Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibitors
#1041GENERATION OF MULTIFUNCTIONAL AND MULTIVALENT POLYPEPTIDE COMPLEXES WITH COLLAGEN XVIII TRIMERIZATION DOMAIN
#1042Method and pharmaceutical composition for use in the treatment of cancer
#1043Protein assembler
#1044Spider silk fusion protein structures incorporating immunoglobulin fragments as affinity ligands
#1045Phase transition biopolymers and methods of use
#1046Use of modified vasoactive intestinal peptides in the treatment of hypertension
#1047METHODS AND TREATMENT WITH GLP-1 RECEPTOR AGONISTS
#1048COMPOSITIONS COMPRISING MODIFIED COLLAGEN AND USES THEREFOR
#1049METHOD OF PRODUCING ORGANIC PRODUCT FROM MOUNTAIN LITSEA
#1050Cysteine engineered fibronectin type III domain binding molecules
#1051CD40L-specific TN3-derived scaffolds and methods of use thereof
#1052Peptide fragments for inducing synthesis of extracellular matrix proteins
#1053Therapeutic agents comprising fusions of growth hormone and elastic peptides
#1054Fibronectin based scaffold domain proteins that bind to myostatin
#1055METHOD FOR MAKING A FIBRE COMPRISING NATURAL FIBRE NANOPARTICLES
#1056Reagents and methods for treating dental disease
#1057Crosslinked human or animal tissue products and their methods of manufacture and use
#1058Fibronectin binding domains with reduced immunogenicity
#1059Bifunctional peptide
#1060Collagen 7 and related methods
#1061Modified collagen
#1062Catalyst and process for preparing acrolein and/or acrylic acid by dehydration reaction of glycerin
#1063Method for enzymatic treatment of tissue products
#1064SPARC binding ScFcs
#1065Regeneration and repair of mesenchymal tissue using amelogenin
#1066DIRECT DRUG DELIVERY SYSTEM BASED ON THERMALLY RESPONSIVE BIOPOLYMERS
#1067METHOD OF PRODUCING COLLAGEN FROM HYDROLYZED EGG MEMBRANE
#1068Multivalent fibronectin based scaffold domain proteins
#1069Methods of enhancing genetic diagnosis
#1070ENGINEERING MULTIFUNCTIONAL AND MULTIVALENT MOLECULES WITH COLLAGEN XV TRIMERIZATION DOMAIN
#1071SPARC binding ScFcs
#1072SPARC binding ScFvs
#1073Foam-formed collagen strand
#1074Self-healing material and method for the preparation thereof
#1075Fibrous protein processing method
#1076Activated collagen scaffold materials and their special fused active restoration factors
#1077Integrin-blocking polypeptides and uses thereof
#1078Peptide preparations and peptides with antitumour activity
#1079Active small-molecule donkey-hide gelatin mixture and preparation method and application thereof
#1080Cell culture substrate comprising a laminin and a cadherin
#1081Activated collagen scaffold materials and their special fused active restoration factors
#1082DPP-4 inhibitor
#1083Fibronectin based scaffold domain proteins that bind to myostatin
#1084Collagen powder
#1085MEANS AND METHODS FOR TREATING ANGIOGENESIS-RELATED DISEASES
#1086Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
#1087Antagonist peptide of the bond between CD47 and a protein belonging to the thrombospondin family
#1088Matricryptic ECM peptides for tissue reconstruction
#1089Method for producing a collagen membrane and uses thereof
#1090Antibody and antibody mimetic for visualization and ablation of endogenous proteins
#1091Platelet aggregation inducing substance
#1092Complexation of fatty acid-conjugated molecules with albumin
#1093Methods and compositions involving fibrillizing polypeptides for nanofibers
#1094Method For Producing Peptide Fractions And Use Thereof
#1095Thermosensitive, bioactive biopolymer and associated method of cell harvesting
#1096Collagen matrix with locally controlled intrafibrillar and extrafibrillar mineral content and methods of producing
#1097Compositions of a peptide targeting system for treating cancer
#1098Antibody-endostatin fusion protein and its variants
#1099Therapeutic agents comprising fusions of insulin and elastic peptides
#1100UNIVERSAL FIBRONECTIN TYPE III BINDING-DOMAIN LIBRARIES
#1101SILK-ELASTIN LIKE PROTEIN POLYMERS FOR EMBOLIZATION AND CHEMOEMBOLIZATION TO TREAT CANCER
#1102Use of endostatin peptides for the treatment of fibrosis
#1103Method and apparatus for data transmission using multiple transmit antennas
#1104Surface-active collagen membrane by peptide
#1105Multi-hierarchical self-assembly of a collagen mimetic peptide
#1106METHODS FOR MAINTAINING PEGYLATION OF POLYPEPTIDES
#1107Inhibitors of type 2 vascular endothelial growth factor receptors
#1108Transferrin-tumstatin fusion protein and methods for producing and using the same
#1109Antigen peptide and uses thereof
#1110Production of carrier-peptide conjugates using chemically reactive unnatural amino acids
#1111Designer collagens and use thereof
#1112EGFR and C-Met fibronectin type III domain binding molecules
#1113EGFR and c-Met fibronectin type III domain binding molecules
#1114Method of using papain to extract collagen from aquatic animals
#1115Protein scaffolds
#1116Universal fibronectin type III binding-domain libraries
#1117Antibodies of the ED-B domain of fibronectin, their construction and uses
#1118Method for producing collagen-like polypeptide
#1119Modified laminin and use thereof
#1120Recombinant human fibronectin fragment for cell culture
#1121Fc fusion proteins comprising novel linkers or arrangements
#1122Production and delivery of a stable collagen
#1123Fibronectin based scaffold domain proteins that bind to myostatin
#1124Fibronectin based scaffold domain proteins that bind to myostatin
#1125System and method for collagen isolation
#1126Cell-adhesive protein
#1127Methods of making bioactive collagen medical scaffolds such as for wound care dressings, hernia repair prosthetics, and surgical incision closure members
#1128Biomaterial of chymotryptically isolated fraction of fibroin in a hydrogel
#1129REGENERATION AND REPAIR OF MESENCHYMAL TISSUE USING AMELOGENIN
#1130COLLAGEN HYDROXYLASES
#1131Biphasic collagen membrane or capsule for guided tissue regeneration
#1132Method for isolating osteopontin using concentrated feeds
#1133Functionalized biomaterials for tissue regeneration
#1134RECOMBINANT VECTOR, TRANSGENIC FISH EGG USING THE SAME AND BIOMATERIAL USING THE SAME
#1135Fibronectin cradle molecules and libraries thereof
#1136Gelatin alkyd peptides and uses thereof
#1137Aldosterone induced vascular elastin production
#1138PEPTIDE COMPOSITIONS THAT DOWNREGULATE TLR-4 SIGNALING PATHWAY AND METHODS OF PRODUCING AND USING SAME
#1139Compositions having antiangiogenic activity and uses thereof
#1140Method of treating a disease or condition characterised by aberrant epithelial cell proliferation
#1141High-strength collagen fiber membrane and a manufacturing method thereof
#1142Targeted therapeutics based on engineered proteins that bind EGFR
#1143High molecular ordered fibrilar structures, method for their preparation and uses thereof
#1144Stabilized fibronectin domain compositions, methods and uses
#1145Extracellular matrix heparin-binding domains
#1146Human placental collagen compositions, and methods of making and using the same
#1147Methods for treating metabolic syndrome with Cthrc1 polypeptide
#1148Activity enhancer for anticancer agent
#1149Bioactive peptides and methods of using same
#1150Matrix scaffold with antimicrobial activity
#1151NON-FIBROGENESIS COLLAGEN MATERIAL AND A MANUFACTURING METHOD THEREOF
#1152Chimeric fibronectin matrix mimetics and uses therof
#1153Assay for colon and other cancers in humans
#1154Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphagiogenesis-dependent diseases
#1155Respiratory syncytial virus vaccine
#1156Cartilage oligomeric matrix protein (COMP)—growth factor complexes and uses thereof
#1157EXTRACT OF AQUATIC ANIMAL CARTILAGE
#1158Glycation cross-link breakers to increase resistance to enzymatic degradation
#1159METHODS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS WITH ENHANCED PHARMACOLOGICAL PROPERTIES
#1160Hybridoma cell line for producing antibody for type II collagen
#1161Preparation and/or formulation of proteins cross-linked with polysaccharides
#1162Collagen producing plants and methods of generating and using same
#1163Compositions and methods for the treatment of orthopedic disease or injury
#1164Fibronectin based scaffold domain proteins that bind IL-23
#1165RADIATION CROSS-LINKED COLLAGEN GEL, AND PREPARATION METHOD AND USAGE METHOD THEREOF
#1166Biocomposites and methods of making the same
#1167Phase transition biopolymers and methods of use
#1168Amniotic membrane preparations and purified compositions and anti-inflammation methods
#1169Non-natural gelatin-like proteins with enhanced functionality
#1170ARTIFICIAL ANTIBODY POLYPEPTIDES
#1171COLLAGENOUS MATERIAL
#1172Polynucleotides encoding therapeutic inhibitors of PAI-1
#1173Recombinant proteins having haemostatic activity and capable of inducing platelet aggregation
#1174Method for use of a double-structured tissue implant for treatment of tissue defects
#1175Implantation material comprising biocompatible polymer
#1176Fibronectin binding domains with reduced immunogenicity
#1177Reconstituted polypeptides
#1178COLLAGEN
#1179Human placental collagen compositions, and methods of making and using the same
#1180COMPOSITIONS AND METHODS FOR PRODUCING BIOACTIVE FUSION PROTEINS
#1181Fibronectin based scaffold domain proteins that bind PCSK9
#1182Nonnatural collagen-like protein and use thereof
#1183Decellularized adipose cell growth scaffold
#11843D MATRICES OF HUMAN ELASTIN-LIKE POLIPEPTIDES AND METHOD OF PREPARATION THEREOF
#1185Controlled release of ocular biopharmaceuticals using bioresponsive protein polymers
#1186Fibronectin binding domains with reduced immunogenicity
#1187Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
#1188Purified amniotic membrane compositions and methods of use
#1189Oriented collagen/apatite material and method for producing oriented collagen/apatite material
#1190Fibronectin based scaffold proteins having improved stability
#1191HUMAN PLACENTAL COLLAGEN COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME
#1192RGD-containing cyclic peptides
#1193Expression and export of angiogenesis inhibitors as immunofusins
#1194Method for treating ocular neovascularization
#1195METHOD FOR CULTURING CELLS IN A SYSTEM COMPRISING LAMININ-5
#1196Tropoelastins and uses thereof
#1197TNF receptor Fc fusion proteins and in vivo methods of use
#1198Collagen mimetic peptides for targeting collagen strands for in vitro and in vivo imaging and therapeutic use
#1199Compositions and methods directed to treating liver fibrosis
#1200Bispecific EGFR/IGFIR binding molecules